Related Experiment Video
Updated: Jul 9, 2026
09:04
Rearing and Injection of Manduca sexta Larvae to Assess Bacterial Virulence
Published on: December 11, 2012
Summary
Malaria vaccine developers are using new technologies to target the parasite at all life cycle stages. A successful, life-saving malaria vaccine is predicted within 5-10 years, though defining "success" has challenges.
Area of Science:
- Malariology
- Vaccinology
- Parasitology
Background:
- Significant advancements in vaccine development technologies are being employed to combat the malaria parasite.
- Research efforts are focused on targeting the parasite across its entire complex life cycle.
Discussion:
- The definition of a
- successful
- malaria vaccine requires careful consideration of efficacy and impact.
- Challenges remain in achieving complete parasite clearance and preventing transmission.
Key Insights:
- New technologies offer novel strategies for malaria vaccine development.
- Predictive models suggest a viable malaria vaccine could emerge within the next decade.
- Defining and measuring vaccine success in malaria is a critical, ongoing discussion.
Outlook:
- Continued innovation in vaccine technology is expected to accelerate progress.
- The development of a life-saving malaria vaccine remains a high priority in global health.
- Overcoming the complexities of the malaria parasite's life cycle is key to achieving vaccine efficacy.
Related Concept Videos
01:51Vaccinations
Overview
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:30Reservoir of Infection
Infectious diseases arise from intricate interactions between pathogens and their reservoirs. A reservoir of infection refers to the natural habitat where a pathogen lives, grows, and multiplies, serving as a continual source of infection. Reservoirs are broadly classified as either living or nonliving, and each plays a unique role in disease transmission, significantly influencing public health interventions and control strategies.Humans act as reservoirs for a wide array of pathogens,...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...